ArticleBMC public health2025
Assessing the impact of COVID-19 on HIV and hepatitis B testing in Western Iran: insights from an interrupted time series analysis.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Future of Newly Diagnosed HIV Cases in Iran Through 2030: A Mixed-Methods Trend Impact Analysis.HIV/AIDS (Auckland, N.Z.) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe COVID-19 pandemic significantly disrupted healthcare systems worldwide, affecting the delivery of essential diagnostic services. HIV and HBV testing services, critical for the timely detection and management of these diseases, experienced substantial declines during the pandemic. This study aimed to assess the impact of the COVID-19 pandemic on HIV and HBV testing rates in western Iran.
methodsWe conducted an interrupted time series analysis using data on monthly HIV and HBV testing rates from Behavioral Health Counseling Centers in western Iran. The study period spanned from January 2017 to December 2023, divided into pre-pandemic (January 2017-December 2019) and pandemic (January 2020-December 2023) phases. We modeled the immediate level changes and trends in testing rates post-pandemic onset, accounting for pre-existing trends. Regression analysis provided estimates of changes in testing rates, with 95% confidence intervals (CI).
resultsThe analysis revealed a significant decline in HIV testing rates, with an immediate reduction of 145.02 tests per month (95% CI: -159.78 to -130.26). A similar impact was observed for HBV testing, which decreased by 86.50 tests per month (95% CI: -95.51 to -77.49). While a recovery trend was observed for HIV testing over subsequent months, HBV testing exhibited a slower rebound. The disruptions were attributed to resource reallocation, movement restrictions, and reduced healthcare access during the pandemic.
conclusionThe COVID-19 pandemic led to substantial disruptions in HIV and HBV diagnostic services in western Iran, underscoring the vulnerability of essential healthcare services to public health emergencies. Although recovery trends were observed, the slower rebound in HBV testing highlights the need for tailored interventions. Strengthening healthcare system resilience, ensuring resource allocation for routine diagnostics, and integrating pandemic preparedness into health policies are crucial to mitigating the impact of future crises.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.